MSCT complements endoscopic ultrasound in gastrointestinal cancer staging
While both multislice CT and endoscopic ultrasound can evaluate the local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam, providing superior staging of T3 and T4 cancers, according to a study from Austria presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.
While both multislice CT and endoscopic ultrasound can evaluate the local extension of esophageal tumors, CT can also image distant metastases in the lymph nodes, lungs, and liver with a single exam, providing superior staging of T3 and T4 cancers, according to a study from Austria presented at the 2005 European Congress of Radiology. CT is not without weaknesses, however.
Dr. Ahmed Ba-Ssalamah, a radiologist at the Medical University of Vienna, and colleagues enrolled 23 patients with esophageal carcinoma. Patients underwent endoscopic sonography and contrast-enhanced MSCT scanning using a gas-water GI-filling technique.
Endoscopic ultrasound and MSCT each provided a 100% sensitivity rate for tumor detection, but the sensitivity of other endpoints varied. Ultrasound was favored for tumor staging (89% versus 79%) and for diagnosis of local node involvement (82% versus 76%). CT came out on top in diagnosing distant node involvement and other metastases (65% versus 92%).
The researchers performed ultrasound scanning using a fiber-optic endoscope with a 5-1-MHz electronic array that provides a 360° scanning angle. They performed CT with a 16-slice scanner and a bowel distention protocol including gas granules and water for the esophagus and stomach, respectively, and a contrast injection using a bolus-tracking technique.
Their acquisition protocol included slice thicknesses of 0.5 mm and 1.5 mm, respectively, for the thoracocervical and abdominal regions. They used postsurgical histopathologic results as their comparative gold standard.
MSCT offers a field-of-view depth superior to endoscopic ultrasound for staging and detection of local disease and distant lymph node metastases, Ba-Ssalamah said. But MSCT isn't perfect Differentiation between T1 and T2 stages using the bowel distention-plus contrast technique is difficult, if not impossible. And MSCT's spatial resolution is still inferior to endoscopic ultrasound.
Clinical experience in the preoperative staging of esophageal cancer indicates that the two techniques are complementary rather than competitive in this realm, he said.
For more information from the Diagnostic Imaging archives:
Virtual endoscopy detects, characterizes gastric cancer
Anatomic, functional imaging collaborate in cancer detection
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
